{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:25:32Z","timestamp":1792016732954,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008900.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000}}],"reference-count":141,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008900.pub3","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T16:29:05Z","timestamp":1573489745000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cerebrolysin for vascular dementia"],"prefix":"10.1002","author":[{"given":"Shuhui","family":"Cui","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37 Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37 Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Yang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37 Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37 Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muke","family":"Zhou","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37 Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairong","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Public Health, Sichuan University; Epidemic Disease & Health Statistics Department; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37 Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"key":"10.1002\/14651858.CD008900.pub3-BIB0001|cit1","first-page":"391","article-title":"Cerebrolysin improves clinical outcome in moderate to moderately severe vascular dementia: results from a randomized, double-blind, placebo-controlled, multicenter trial","volume":"16 (Suppl 3)","author":"Guekht","year":"2009","journal-title":"European Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD008900.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.01.012","article-title":"Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial","volume":"20","author":"Guekht","year":"2011","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0003|cit3","unstructured":"NCT00947531 A clinical trial to evaluate the safety and efficacy of 20 ml Cerebrolysin in patients with Vascular Dementia (VascDem) clinicaltrials.gov\/ct2\/show\/study\/NCT00947531"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0004|cit4","first-page":"75","article-title":"The efficacy of Cerebrolysin in multi-infarct dementia","volume":"24","author":"Liang","year":"2001","journal-title":"Heilongjiang Medicine and Pharmacy"},{"issue":"1-2","key":"10.1002\/14651858.CD008900.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2007.10.016","article-title":"A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration","volume":"267","author":"Muresanu","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"issue":"1-2","key":"10.1002\/14651858.CD008900.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2010.08.040","article-title":"Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study","volume":"299","author":"Muresanu","year":"2010","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0007|cit7","first-page":"6","article-title":"Mild forms of multi-infarct dementia - effectiveness of Cerebrolysin","volume":"11","author":"Vereschagin","year":"1991","journal-title":"Sovetskaya Meditsina"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0008|cit8","first-page":"13","article-title":"The efficacy of Cerebrolysin in patients with vascular dementia: results of a Chinese multicentre, randomised, double-blind, placebo-controlled trial","volume":"9","author":"Xiao","year":"1999","journal-title":"Hong Kong Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0009|cit9","first-page":"1","article-title":"A multi-center, double blind, placebo-controlled trial of the efficacy of Cerebrolysin in treatment of vascular dementia","volume":"9","author":"Xiao","year":"1999","journal-title":"Journal of Clinical Psychological Medicine"},{"issue":"28","key":"10.1002\/14651858.CD008900.pub3-BIB0010|cit10","first-page":"3850","article-title":"Cerebrolysin improves the intelligence of vascular dementia patients in clinic","volume":"7","author":"Zhang","year":"2003","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"22","key":"10.1002\/14651858.CD008900.pub3-BIB0011|cit11","first-page":"71","article-title":"Comparative study of citicoline and cerebrolysin for cerebrovascular disease and vascular dementia","volume":"2","author":"Alkebaiker","year":"2014","journal-title":"Chinese Journal of Hypertension"},{"issue":"15","key":"10.1002\/14651858.CD008900.pub3-BIB0012|cit12","first-page":"986","article-title":"Application of Cerebrolysin in ischaemic cerebrovascular disease","volume":"21","author":"Cao","year":"2000","journal-title":"Clinical Focus"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0013|cit13","first-page":"1019","article-title":"Efficacy of Cerebrolysin for vascular dementia","volume":"9","author":"Chen","year":"2006","journal-title":"Chinese Journal of Practical Medicine"},{"issue":"11","key":"10.1002\/14651858.CD008900.pub3-BIB0014|cit14","first-page":"72","article-title":"Efficacy of galanthamine in patients with vascular dementia","volume":"8","author":"Chen","year":"2014","journal-title":"Journal of North Pharmacy"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0015|cit15","first-page":"44","article-title":"Efficacy of Cerebrolysin in 41 patients with vascular dementia","volume":"15","author":"Dai","year":"2011","journal-title":"Chinese and Foreign Medical Research"},{"issue":"6","key":"10.1002\/14651858.CD008900.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11055-008-9014-5","article-title":"Effects of Cerebrolysin on moderate cognitive impairments in cerebral vascular insufficiency (a clinical-electrophysiological study)","volume":"38","author":"Damulin","year":"2008","journal-title":"Neuroscience and Behavioral Physiology"},{"issue":"8","key":"10.1002\/14651858.CD008900.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.17116\/jnevro20171178127-38","article-title":"Therapeutic monitoring and prediction of the efficacy of neurotrophic treatment in patients with amnestic type of mild cognitive impairment","volume":"117","author":"Gavrilova","year":"2017","journal-title":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova"},{"issue":"12","key":"10.1002\/14651858.CD008900.pub3-BIB0018|cit18","first-page":"189","article-title":"The application value of cerebrolysin in multi-infarction dementia","volume":"13","author":"Han","year":"2015","journal-title":"Guide of China Medicine"},{"issue":"7","key":"10.1002\/14651858.CD008900.pub3-BIB0019|cit19","first-page":"164","article-title":"Comparative study of citicoline and cerebrolysin for cerebrovascular disease and vascular dementia","volume":"12","author":"Hao","year":"2015","journal-title":"China Continuing Medical Education"},{"issue":"3","key":"10.1002\/14651858.CD008900.pub3-BIB0020|cit20","first-page":"129","article-title":"Application of Cerebrolysin in 30 patients of post stroke dementia","volume":"10","author":"Jia","year":"1991","journal-title":"New Drugs and Clinical Remedies"},{"issue":"17","key":"10.1002\/14651858.CD008900.pub3-BIB0021|cit21","first-page":"41","article-title":"Application of Cerebrolysin in 20 patients with vascular dementia","volume":"5","author":"Li","year":"1996","journal-title":"Anhui Medicine"},{"issue":"12","key":"10.1002\/14651858.CD008900.pub3-BIB0022|cit22","first-page":"195","article-title":"Efficacy of cerebrolysin for elderly dementia","volume":"36","author":"Li","year":"2014","journal-title":"Guide of China Medicine"},{"issue":"13","key":"10.1002\/14651858.CD008900.pub3-BIB0023|cit23","first-page":"289","article-title":"Comparative study of citicoline and cerebrolysin for patients comorbid with cerebrovascular disease and vascular dementia","volume":"17","author":"Liu","year":"2015","journal-title":"Contemporary Medical Symposium"},{"issue":"12","key":"10.1002\/14651858.CD008900.pub3-BIB0024|cit24","first-page":"1748","article-title":"Oxiracetam combined with cerebroprotein hydrolysate injection for treating cognitive dysfunction after stroke and its influence on serum Hcy and hs-CRP levels","volume":"34","author":"Liu","year":"2017","journal-title":"Journal of Guangxi Medical University"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0025|cit25","first-page":"25","article-title":"The efficacy of Cerebrolysin for 62 old patients with vascular dementia","volume":"22","author":"Meng","year":"2001","journal-title":"Journal of Mudanjiang Medical College"},{"issue":"18","key":"10.1002\/14651858.CD008900.pub3-BIB0026|cit26","first-page":"147","article-title":"Efficacy of Cerebrolysin in 20 patients with vascular dementia","volume":"3","author":"Pan","year":"1999","journal-title":"Herald of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0027|cit27","first-page":"57","article-title":"Efficacy of prolonged therapy of vascular dementia","volume":"89","author":"Shprakh","year":"2011","journal-title":"Klinicheskaia Meditsina"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0029|cit28","article-title":"Clinical efficacy of prolonged course of cerebrolysin therapy in patients with poststroke vascular dementia","author":"Suvorova","year":"2010","journal-title":"New Armenian Medical Journal"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0028|cit29","doi-asserted-by":"crossref","first-page":"S561","DOI":"10.1016\/S0924-977X(10)70847-6","article-title":"Neuroprotective therapy in basic treatment of vascular dementia","volume":"20","author":"Suvorova","year":"2010","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jns.2009.02.177","article-title":"The efficacy of cerebrolysin in vascular dementia","volume":"283","author":"Tapu","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0031|cit31","first-page":"22","article-title":"Treatment and prevention of cognitive dysfunction in patients with arterial hypertension and atherosclerosis: results of randomised double blind placebo-controlled study of cerebrolysin","volume":"73","author":"Vereschagin","year":"2001","journal-title":"Terapevticheskii Arkhiv"},{"issue":"4","key":"10.1002\/14651858.CD008900.pub3-BIB0032|cit32","first-page":"244","article-title":"Comparative study of cytidine diphosphate choline and cerebrolysin for cerebrovascular disease and vascular dementia","volume":"15","author":"Wang","year":"1996","journal-title":"New Drugs and Clinical Remedies"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0033|cit33","first-page":"362","article-title":"Efficacy of cerebrolysin in patients with multi-infarct dementia","volume":"12","author":"Wang","year":"2003","journal-title":"Proceeding of Clinical Medicine"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0034|cit34","first-page":"1836","article-title":"Comparative study of citicoline and cerebrolysin for cerebrovascular disease and vascular dementia","volume":"10","author":"Wang","year":"2015","journal-title":"Journal of Clinical Medicine"},{"issue":"10","key":"10.1002\/14651858.CD008900.pub3-BIB0035|cit35","first-page":"136","article-title":"Comparative study of citicoline and cerebrolysin for cerebrovascular disease and vascular dementia","volume":"30","author":"Wang","year":"2016","journal-title":"For All Health"},{"issue":"75","key":"10.1002\/14651858.CD008900.pub3-BIB0036|cit36","first-page":"14804","article-title":"Comparative study of citicoline and cerebrolysin for patients comorbid with cerebrovascular disease and vascular dementia","volume":"4","author":"Wang","year":"2017","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008900.pub3-BIB0037|cit37","first-page":"678","article-title":"Comparative study of citicoline and cerebrolysin for cerebrovascular disease and vascular dementia","volume":"50","author":"Wang","year":"2018","journal-title":"Inner Mongolia Medical Journal"},{"issue":"16","key":"10.1002\/14651858.CD008900.pub3-BIB0038|cit38","first-page":"3022","article-title":"Effect of galanthamine on memory and quality of life in patients with vascular dementia","volume":"8","author":"Xian","year":"2004","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"30","key":"10.1002\/14651858.CD008900.pub3-BIB0039|cit39","first-page":"85","article-title":"Jiannaoyizhi decoction combined with acupoint injection of cerebrolysin in treatment of senile vascular dementia randomized controlled study","volume":"12","author":"Xu","year":"2016","journal-title":"Journal of Practical Traditional Chinese Internal Medicine"},{"issue":"16","key":"10.1002\/14651858.CD008900.pub3-BIB0040|cit40","first-page":"95","article-title":"Comparative study of citicoline and cerebrolysin for cerebrovascular disease and vascular dementia","volume":"22","author":"Xue","year":"2016","journal-title":"World Latest Medicine Information"},{"issue":"31","key":"10.1002\/14651858.CD008900.pub3-BIB0041|cit41","first-page":"1134","article-title":"Efficacy of xingnaojing combined with venortuon and cerebrolysin in 60 patients with vascular dementia","volume":"12","author":"Zhao","year":"2015","journal-title":"Journal of Practical Traditional Chinese Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0042|cit42","first-page":"80","article-title":"Efficacy of Xuesaitong decoction combined with Cerebrolysin in 50 patients with poststroke dementia","volume":"10","author":"Zhao","year":"2017","journal-title":"Global Traditional Chinese Medicine"},{"issue":"3","key":"10.1002\/14651858.CD008900.pub3-BIB0043|cit43","first-page":"103","article-title":"Efficacy of cerebrolysin for vascular dementia","volume":"22","author":"Zheng","year":"1999","journal-title":"Heilongjiang Medicine and Pharmacy"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-2006-956757","article-title":"Vascular dementia: emerging trends","volume":"27","author":"Aggarwal","year":"2007","journal-title":"Seminars in Neurology"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0045|cit45","first-page":"213","article-title":"Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain","volume":"7","author":"Akai","year":"1992","journal-title":"Histology and Histopathology"},{"issue":"11","key":"10.1002\/14651858.CD008900.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/syn.21588","article-title":"Combined administration of cerebrolysin and donepezil induces plastic changes in prefrontal cortex in aged mice","volume":"66","author":"Alc\u00e1ntara-Gonz\u00e1lez","year":"2012","journal-title":"Synapse"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1358\/dot.2012.48(Suppl.A).1739721","article-title":"Cerebrolysin improves symptoms and delays progression in patients with Alzheimer's disease and vascular dementia","volume":"48 Suppl A","author":"Allegri","year":"2012","journal-title":"Drugs of Today"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0048|cit48","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0049|cit49","volume-title":"Diagnostic and Statistical Manual of Mental Disorders. 3rd edition, revised","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0050|cit50","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0051|cit51","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"4","key":"10.1002\/14651858.CD008900.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3233\/JAD-150136","article-title":"Translation of pre-clinical studies into successful clinical trials for alzheimer's disease: what are the roadblocks and how can they be overcome?","volume":"47","author":"Banik","year":"2015","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/STROKEAHA.107.490672","article-title":"Diagnostic criteria of vascular dementia in CADASIL","volume":"39","author":"Benisty","year":"2008","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0054|cit54","article-title":"Rivastigmine for vascular cognitive impairment","author":"Birks","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1358\/dot.2012.48(Suppl.A).1739723","article-title":"Accelerated recovery from acute brain injuries: clinical efficacy of neurotrophic treatment in stroke and traumatic brain injuries","volume":"48 Suppl A","author":"Bornstein","year":"2012","journal-title":"Drugs of Today"},{"issue":"4","key":"10.1002\/14651858.CD008900.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/YCO.0000000000000511","article-title":"Dementia care: international perspectives","volume":"32","author":"Burns","year":"2019","journal-title":"Current Opinion in Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD008900.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/j.1742-1241.2011.02810.x","article-title":"The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies","volume":"65","author":"Chang","year":"2011","journal-title":"International Journal of Clinical Practice"},{"issue":"6","key":"10.1002\/14651858.CD008900.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/02688697.2013.793287","article-title":"Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study","volume":"27","author":"Chen","year":"2013","journal-title":"British journal of neurosurgery"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0059|cit59","article-title":"Cerebrolysin for vascular dementia","author":"Chen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-24248-8","article-title":"Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis","volume":"8","author":"Chu","year":"2018","journal-title":"Scientific reports"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.42.3.473","article-title":"Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centers","volume":"42","author":"Chui","year":"1992","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-015-0104-7","article-title":"Clinical and imaging features of mixed Alzheimer and vascular pathologies","volume":"7","author":"Chui","year":"2015","journal-title":"Alzheimer's research & therapy"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0063|cit63","article-title":"Cochrane Database of Systematic Reviews","author":"Craig","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0064|cit64","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10143-016-0775-y","article-title":"A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury","volume":"41","author":"Sayed","year":"2018","journal-title":"Neurosurgical Review"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"issue":"5-6","key":"10.1002\/14651858.CD008900.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000377672","article-title":"Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials","volume":"39","author":"Gauthier","year":"2015","journal-title":"Dementia and geriatric cognitive disorders"},{"issue":"3","key":"10.1002\/14651858.CD008900.pub3-BIB0068|cit68","first-page":"153","article-title":"Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial","volume":"10","author":"Gharagozli","year":"2017","journal-title":"Journal of medicine and life"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jalz.2016.04.002","article-title":"Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013","volume":"13(1)","author":"Goodman","year":"2017","journal-title":"Alzheimer's & dementia"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0070|cit70","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","article-title":"Cerebral blood flow in dementia","volume":"9","author":"Hachinski","year":"1975","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007365.pub2","article-title":"Huperzine A for vascular dementia","author":"Hao","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s007020170058","article-title":"Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons","volume":"108","author":"Hartbauer","year":"2001","journal-title":"Journal of Neural Transmission"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/jnnp.2006.109074","article-title":"Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination","volume":"78","author":"Hensel","year":"2007","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD008900.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD008900.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"British medical journal"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0077|cit77","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0078|cit78","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0079|cit79","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0080|cit80","first-page":"331","article-title":"The clinical efficacy of Cerebrolysin in the treatment of acute ischemic stroke","volume":"7","author":"Hong","year":"2005","journal-title":"Chinese Journal of Geriatric Heart Brain and Vessel Diseases"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0081|cit81","first-page":"231","article-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use adopts Consolidated Guideline on Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use","volume":"48","author":"International Conference on Harmonisation Expert Working Group","year":"1997","journal-title":"International Digest of Health Legislation"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1586\/14737175.2014.947276","article-title":"Understanding and preventing the development of post-stroke dementia","volume":"14(9)","author":"Ihara","year":"2014","journal-title":"Expert review of neurotherapeutics"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-121819","article-title":"Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK","volume":"35(3)","author":"Imfeld","year":"2013","journal-title":"Journal of Alzheimer's disease"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0084|cit84","volume-title":"Improving the Utility and Translation of Animal Models for Nervous System Disorders: Workshop Summary","author":"IOM (Institute of Medicine)","year":"2013"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2013.01.012","article-title":"The prevalence of dementia in urban and rural areas of China","volume":"10(1)","author":"Jia","year":"2014","journal-title":"Alzheimer's & dementia"},{"issue":"11","key":"10.1002\/14651858.CD008900.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/syn.20950","article-title":"The chronic administration of cerebrolysin induces plastic changes in the prefrontal cortex and dentate gyrus in aged mice","volume":"65","author":"Ju\u00e1rez","year":"2011","journal-title":"Synapse"},{"issue":"1-2","key":"10.1002\/14651858.CD008900.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jns.2012.03.027","article-title":"Vascular dementia","volume":"322","author":"Korczyn","year":"2012","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD008900.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00702-004-0248-2","article-title":"Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial","volume":"112","author":"Ladurner","year":"2005","journal-title":"Journal of Neural Transmission"},{"issue":"6","key":"10.1002\/14651858.CD008900.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2147\/VHRM.S7343","article-title":"Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review","author":"Ligthart","year":"2010","journal-title":"Vascular health and risk management"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2017.04.022","article-title":"Cerebrolysin alleviates cognitive deficits induced by chronic cerebral hypoperfusion by increasing the levels of plasticity-related proteins and decreasing the levels of apoptosis-related proteins in the rat hippocampus","volume":"651","author":"Liu","year":"2017","journal-title":"Neuroscience letters"},{"issue":"7","key":"10.1002\/14651858.CD008900.pub3-BIB0091|cit91","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007514.pub3","article-title":"Statins for the treatment of dementia","author":"McGuinness","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","article-title":"Post-stroke dementia - a comprehensive review","volume":"15","author":"Mijajlovi\u0107","journal-title":"BMC medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008900.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","article-title":"Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Mohs","year":"1997","journal-title":"Alzheimer Disease & Associated Disorders"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1532-5415.2008.02122.x","article-title":"Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia","volume":"57","author":"Molnar","year":"2009","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(08)70040-1","article-title":"Vascular cognitive impairment: current concepts and clinical developments","volume":"7","author":"Moorhouse","year":"2008","journal-title":"Lancet Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD008900.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2007.10.016","article-title":"A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration","volume":"267","author":"Muresanu","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"issue":"1-2","key":"10.1002\/14651858.CD008900.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jns.2010.08.040","article-title":"Persistence of the effects of Cerebrolysin on cognition and qEEG slowing in vascular dementia patients: results of a 3-month extension study","volume":"299","author":"Muresanu","year":"2010","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD008900.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The\u00a0Montreal\u00a0Cognitive\u00a0Assessment, MoCA: a brief screening tool for mild\u00a0cognitive\u00a0impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"Journal of the American Geriatric Society"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"89-98","DOI":"10.1016\/S1474-4422(03)00305-3","article-title":"Vascular cognitive impairment","volume":"2","author":"O'Brien","year":"2003","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/01.JGP.0000231780.44684.7e","article-title":"Vascular cognitive impairment","volume":"14","author":"O'Brien","year":"2006","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"10004","key":"10.1002\/14651858.CD008900.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O'Brien","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1212\/WNL.0000000000003932","article-title":"Trends in dementia prevalence, incidence, and survival rate in a Japanese community","volume":"88(20)","author":"Ohara","year":"2017","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF02339212","article-title":"Hachinski's ischemic score and the diagnosis of vascular dementia: a review","volume":"14","author":"Pantoni","year":"1993","journal-title":"Italian Journal of Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD008900.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12603-012-0042-z","article-title":"Nutrition and vascular dementia","volume":"16","author":"Perez","year":"2012","journal-title":"journal of nutrition, health & aging"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000109998","article-title":"Prevalence of dementia in the United States: the aging, demographics, and memory study","volume":"29(1-2)","author":"Plassman","year":"2007","journal-title":"Neuroepidemiology"},{"issue":"11","key":"10.1002\/14651858.CD008900.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2165\/11203320-000000000-00000","article-title":"Cerebrolysin: a\u00a0review\u00a0of its use in dementia","volume":"26","author":"Plosker","year":"2009","journal-title":"Drugs and Aging"},{"issue":"3","key":"10.1002\/14651858.CD008900.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/11204820-000000000-00000","article-title":"Spotlight\u00a0on\u00a0cerebrolysin\u00a0in\u00a0dementia","volume":"24","author":"Plosker","year":"2010","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1213\/01.ANE.0000059223.78879.0F","article-title":"Low baseline Bispectral Index of the electroencephalogram in patients with dementia","volume":"96","author":"Renna","year":"2003","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0109|cit109","unstructured":"Nordic Cochrane Centre The Cochrane Collaboration Review Manager 5 (RevMan5) 2014"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00702-004-0181-4","article-title":"Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound cerebrolysin","volume":"112","author":"Rockenstein","year":"2005","journal-title":"Journal of Neural Transmission"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/jnr.20818","article-title":"Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease","volume":"83","author":"Rockenstein","year":"2006","journal-title":"Journal of Neuroscience Research"},{"issue":"3","key":"10.1002\/14651858.CD008900.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00401-006-0166-5","article-title":"Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer's disease","volume":"113","author":"Rockenstein","year":"2007","journal-title":"Acta neuropathologica"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia. Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008900.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0025-7125(02)00008-1","article-title":"Vascular dementia revisited: diagnosis, pathogenesis, treatment, and prevention","volume":"86","author":"Rom\u00e1n","year":"2002","journal-title":"Medical Clinics of North America"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0115|cit115","unstructured":"Ryan R Hill S How to GRADE the quality of the evidence. CCCG. Version 3.0 cccrg.cochrane.org\/author-resources"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jnnp-2011-300881","article-title":"What is the clinically relevant change on the ADAS-Cog?","volume":"83","author":"Schrag","year":"2012","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"British medical journal"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0118|cit118","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjopharm.2009.11.001","article-title":"Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review","volume":"7","author":"Shah","year":"2009","journal-title":"American journal of geriatric pharmacotherapy"},{"issue":"7","key":"10.1002\/14651858.CD008900.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gps.2572","article-title":"Hypertension is a potential risk factor for vascular dementia: systematic review","volume":"26","author":"Sharp","year":"2011","journal-title":"International journal of geriatric psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD008900.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/syn.21912","article-title":"Cerebrolysin improves memory and ameliorates neuronal atrophy in spontaneously hypertensive, aged rats","volume":"70","author":"Solis-Gaspar","year":"2016","journal-title":"Synapse"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0447.2012.01850.x","article-title":"Assessing cognitive changes in the elderly: reliable change indices for the Mini-Mental State Examination","volume":"126","author":"Stein","year":"2012","journal-title":"Acta psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0123|cit123","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD008900.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-002-0636-3","article-title":"The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease","volume":"105","author":"Tatebayashi","year":"2003","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jnr.23142","article-title":"Cerebrolysin modulates pronerve growth factor\/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease","volume":"91","author":"Ubhi","year":"2013","journal-title":"Journal of neuroscience research"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0126|cit126","first-page":"273","article-title":"Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity","volume":"59","author":"Veinbergs","year":"2000","journal-title":"Journal of Neural Transmission Supplement"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/syn.21718","article-title":"Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat","volume":"68","author":"V\u00e1zquez-Roque","year":"2014","journal-title":"Synapse"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00702-007-0630-y","article-title":"Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease","volume":"114","author":"Wei","year":"2007","journal-title":"Journal of Neural Transmission"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0129|cit129","volume-title":"The 10th Revision of the International Classification of Disease and Related Health Problems (ICD-10)","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD008900.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-3-7091-6467-9_25","article-title":"Neurotrophic activities and therapeutic experience with a brain derived peptide preparation","volume":"53","author":"Windisch","year":"1998","journal-title":"Journal of Neural Transmission Supplement"},{"issue":"2","key":"10.1002\/14651858.CD008900.pub3-BIB0131|cit131","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005382.pub2","article-title":"Yizhi capsule for vascular dementia","author":"Wu","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1-2","key":"10.1002\/14651858.CD008900.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2013.11.028","article-title":"Cerebrolysin reduces amyloid-\u03b2 deposits, apoptosis and autophagy in the thalamus and improves functional recovery after cortical infarction","volume":"337","author":"Xing","year":"2014","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3233\/JAD-170856","article-title":"Chinese herbal medicine for vascular dementia: a systematic review and meta-analysis of high-quality randomized controlled trials","volume":"62","author":"Xu","year":"2018","journal-title":"Journal of Alzheimer's disease"},{"issue":"15","key":"10.1002\/14651858.CD008900.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/jnr.22495","article-title":"Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke","volume":"88","author":"Zhang","year":"2010","journal-title":"Journal of neuroscience research"},{"issue":"7","key":"10.1002\/14651858.CD008900.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/STROKEAHA.111.000831","article-title":"Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke","volume":"44","author":"Zhang","year":"2013","journal-title":"Stroke"},{"issue":"4","key":"10.1002\/14651858.CD008900.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3171\/2014.11.JNS14271","article-title":"Cerebrolysin improves cognitive performance in rats after mild traumatic brain injury","volume":"122","author":"Zhang","year":"2015","journal-title":"Journal of neurosurgery"},{"issue":"6","key":"10.1002\/14651858.CD008900.pub3-BIB0137|cit137","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007026.pub3","article-title":"Cerebrolysin for acute ischaemic stroke","author":"Ziganshina","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD008900.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.yic.0000085765.24936.9a","article-title":"Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study","volume":"18","author":"\u00c1lvarez","year":"2003","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1468-1331.2006.01222.x","article-title":"A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease","volume":"13","author":"\u00c1lvarez","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008900.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1468-1331.2010.03092.x","article-title":"Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin","volume":"18","author":"\u00c1lvarez","year":"2011","journal-title":"European Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD008900.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1358\/dot.2011.47.7.1656496","article-title":"Cerebrolysin in Alzheimer's disease","volume":"47","author":"\u00c1lvarez","year":"2011","journal-title":"Drugs Today (Barc)"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008900.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T18:37:22Z","timestamp":1722019042000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008900.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":141,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008900.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]}}}